ERAZABAN
DEAD

Serial Number

79063074

Owner

Dr. Regenold GmbH

Filing Date

Apr 23, 2008

Add to watchlist:

No watchlists yet
View on USPTO

ERAZABAN Trademark

Serial Number: 79063074

ERAZABAN is a trademark filed by Dr. Regenold GmbH on April 23, 2008. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Dr. Regenold GmbH (6 trademarks)

Zöllinplatz 4

Entity Type: 99

HBI No. 1 Limited

10 Norwich Street

Entity Type: 99

Trademark Details

Filing Date

April 23, 2008

Registration Date

Not Registered

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Nov 24, 2018 DENA
DEATH OF INTERNATIONAL REGISTRATION
Nov 23, 2018 DETH
CHANGE OF NAME/ADDRESS REC'D FROM IB
Oct 26, 2017 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Sep 14, 2017 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Aug 25, 2017 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 2, 2010 FINT
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 13, 2010 OPNX
CHANGE OF OWNER RECEIVED FROM IB
Jul 29, 2010 CHLD
FINAL DISPOSITION NOTICE SENT TO IB
Jul 9, 2010 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 9, 2010 FICR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 3, 2010 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 3, 2010 OPNR
ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT
Jul 9, 2009 MAB1
ABANDONMENT - EXPRESS MAILED
Jul 9, 2009 ABN1
TEAS EXPRESS ABANDONMENT RECEIVED
Jul 8, 2009 EXAR
REFUSAL PROCESSED BY IB
Feb 13, 2009 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 21, 2009 RFCS
REFUSAL PROCESSED BY MPU
Jan 21, 2009 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 17, 2009 RFCR
NON-FINAL ACTION WRITTEN
Jan 16, 2009 CNRT
ASSIGNED TO EXAMINER
Jan 15, 2009 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 13, 2009 MAFR
ASSIGNED TO EXAMINER
Jan 7, 2009 DOCK
NEW APPLICATION ENTERED
Jan 7, 2009 NWAP
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 6, 2009 REPR